Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1998 Oct;21(10):763-6.
doi: 10.1002/clc.4960211013.

Propafenone versus procainamide for conversion of atrial fibrillation to sinus rhythm

A V Mattioli  1 , G R Lucchi, D Vivoli, G Mattioli
Affiliations
Clinical Trial

Propafenone versus procainamide for conversion of atrial fibrillation to sinus rhythm

A V Mattioli et al. Clin Cardiol. 1998 Oct.

Abstract

Background and hypothesis: Antiarrhythmic drugs are widely used for treatment of atrial fibrillation (AF) and restoration of sinus rhythm. This prospective, randomized, and controlled study compared the efficiency and safety of propafenone versus procainamide for the treatment of acute AF.

Methods: In all, 117 patients (55 women, 62 men, mean age 64.2 +/- 13 years, median 63 years) who presented with AF were included in the study. Exclusion criteria were signs or symptoms of heart failure on physical examination, recent myocardial infarction or cardiac surgery, cardiogenic shock, or hypotension. Forty-one patients spontaneously recovered sinus rhythm; the remaining 76 patients were randomized to receive propafenone or procainamide. Propafenone was given at a dose of 2 mg/kg body weight intravenously (i.v.) over 30 min. Patients randomized to receive procainamide received a bolus of 100 mg i.v. administered every 5 min up to a maximum dose of 1 g. The clinical characteristics of the two groups were comparable.

Results: The number of patients who recovered sinus rhythm after the treatment was larger in the procainamide-treated group (Group 1) (69.5%) than in the propafenone-treated group (Group 2) (48.7%); p < 0.05. The time required for cardioversion was significantly lower in Group 1 (mean 4.1 +/- 1.3 h), than in Group 2 patients (mean 7.3 +/- 2.6 h) (p < 0.01).

Conclusion: In the present study, procainamide was more effective than propafenone for the treatment of AF of short duration.

PubMed Disclaimer

References

    1. Stroobandt R, Stiels B, Hoebrechts R, on behalf of the Propafenone Atrial Fibrillation Trial Investigators : Propafenone for conversion and prophylaxis of atrial fibrillation. Am J Cardiol 1997; 79: 418–423 - PubMed
    1. Anderson JL: Acute treatment of atrial fibrillation and flutter. Am J Cardiol 1996; 78 (8A): 17–21 - PubMed
    1. Fenster P, Comess KA, Marsh R, Katzenberg C, Hager WD: Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide. Am Heart J 1983; 106: 501–504 - PubMed
    1. Chapman MJ, Moran JL, O'Fathartaigh ML, Peisach AR, Cunningham DN: Management of atrial tachyarrhythmias in the critically ill: A comparison of intravenous procainamide and amiodarone. Intens Care Med 1993; 19: 48–52 - PubMed
    1. Prystowsky EN, Benson DW, Fuster V, Hart GH, Kay GN, Myerburg RJ, Naccarelli GV, Wyse DG: Management of patients with atrial fibrillation. A statement for healthcare professionals from the subcommittee on electrocardiography and electrophysiology American Heart Association. Circulation 1996; 93: 1262–1277 - PubMed